lymphadenopathy

From Aaushi
Jump to navigation Jump to search

Etiology

* < 1% of lymphadenopathy in primary care due to malignancy

* risk of malignancy increases with age & chronicity

* younger persons are more likely to have infectious cause

Pathology

Clinical manifestations

Laboratory

* NEJM knowledge+ seems to endorse fine needle aspiration followed by a core biopsy (maybe not)[7]

Radiology

Differential diagnosis

Management

  • infection
  • other specifically directed therapy
  • 50% of lymph node biopsies are non diagnostic
  • 25% of patients with non-diagnostic biopsies develop disease in 1 year
  • observation (without laboratory testing or imaging) for

More general terms

More specific terms

Additional terms

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 603-604
  2. 2.0 2.1 2.2 Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 17, 10. American College of Physicians, Philadelphia 1998, 2012, 2015, 2022
  3. Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 324
  4. Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol. 1993 Dec;20(6):570-82. PMID: https://www.ncbi.nlm.nih.gov/pubmed/8296196
  5. Sahai S. Lymphadenopathy. Pediatr Rev. 2013 May;34(5):216-27. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23637250
  6. Soldes OS, Younger JG, Hirschl RB. Predictors of malignancy in childhood peripheral lymphadenopathy. J Pediatr Surg. 1999 Oct;34(10):1447-52. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10549745
  7. 7.0 7.1 NEJM Knowledge+ Complex Medical Care

Patient information

lymphadenopathy patient information